Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Azacytidine

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Azacytidine: Sponsors, patents, clinical trial progress

Azacytidine is an investigational drug.

There have been 124 clinical trials for Azacytidine. The most recent clinical trial was a Phase 3 trial, which was initiated on August 13th 2019.

The most common disease conditions in clinical trials are Myelodysplastic Syndromes, Preleukemia, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and Celgene Corporation.

Recent Clinical Trials for Azacytidine
Azacitidine and Venetoclax in Treating Patients With High Risk Acute Myeloid Leukemia in RemissionNational Cancer Institute (NCI)Phase 2
Azacitidine and Venetoclax in Treating Patients With High Risk Acute Myeloid Leukemia in RemissionM.D. Anderson Cancer CenterPhase 2
Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination TherapyTolero Pharmaceuticals, Inc.Phase 2

See all Azacytidine clinical trials

Clinical Trial Summary for Azacytidine

Top disease conditions for Azacytidine
Top clinical trial sponsors for Azacytidine

See all Azacytidine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.